A Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of TA-46 in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 21 Jun 2018
At a glance
- Drugs TA-46 (Primary)
- Indications Achondroplasia
- Focus Adverse reactions
- 21 Jun 2018 According to a Therachon media release, company to enable clinical trial applications in early 2019.
- 16 Feb 2018 New trial record
- 14 Feb 2018 According to a Therachon media release, the first subject from this trial has been dosed.